These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21423124)

  • 1. Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT.
    Mohty B; Thomas Y; Vukicevic M; Nagy M; Levrat E; Bernimoulin M; Kaiser L; Roosnek E; Passweg J; Chalandon Y
    Bone Marrow Transplant; 2012 Feb; 47(2):236-42. PubMed ID: 21423124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients.
    Reid G; Huprikar S; Patel G; Razonable RR; Mossad S; Levi M; Gregg K; Shoham S; Humar A; Adams W; Kumar D
    Transpl Infect Dis; 2013 Oct; 15(5):487-92. PubMed ID: 23890293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2009 pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients.
    Cost C; Brock E; Adams-Huet B; Siegel JD; Ardura MI
    Pediatr Blood Cancer; 2011 Jan; 56(1):127-33. PubMed ID: 20973099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.
    Ryoo SM; Kim WY; Sohn CH; Seo DW; Oh BJ; Lee JH; Lee YS; Lim KS
    Influenza Other Respir Viruses; 2013 Sep; 7(5):833-7. PubMed ID: 23279949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients.
    Ljungman P; de la Camara R; Perez-Bercoff L; Abecasis M; Nieto Campuzano JB; Cannata-Ortiz MJ; Cordonnier C; Einsele H; Gonzalez-Vicent M; Espigado I; Halter J; Martino R; Mohty B; Sucak G; Ullmann AJ; Vázquez L; Ward KN; Engelhard D; ;
    Haematologica; 2011 Aug; 96(8):1231-5. PubMed ID: 21546495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.
    Tramontana AR; George B; Hurt AC; Doyle JS; Langan K; Reid AB; Harper JM; Thursky K; Worth LJ; Dwyer DE; Morrissey CO; Johnson PD; Buising KL; Harrison SJ; Seymour JF; Ferguson PE; Wang B; Denholm JT; Cheng AC; Slavin M
    Emerg Infect Dis; 2010 Jul; 16(7):1068-75. PubMed ID: 20587176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and clinical characteristics of pandemic (H1N1) 2009 influenza infection in pediatric hemato-oncology and hematopoietic stem cell transplantation patients.
    Babor F; Grund S; Siepermann M; Oommen PT; Kuhlen M; Schuster FR; Laws HJ; Wessalowski R; Bienemann K; Janßen G; Adams O; Borkhardt A; Meisel R
    Transpl Infect Dis; 2012 Dec; 14(6):589-94. PubMed ID: 23013490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
    Yu H; Liao Q; Yuan Y; Zhou L; Xiang N; Huai Y; Guo X; Zheng Y; van Doorn HR; Farrar J; Gao Z; Feng Z; Wang Y; Yang W
    BMJ; 2010 Sep; 341():c4779. PubMed ID: 20876641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
    Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
    Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H1N1 infection in a cohort of hematopoietic stem cell transplant recipients: prompt antiviral therapy might be life saving.
    Suyani E; Aki Z; Güzel Ö; Altindal S; Senol E; Sucak G
    Transpl Infect Dis; 2011 Apr; 13(2):208-12. PubMed ID: 21214698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections with the 2009 H1N1 influenza virus among hematopoietic SCT recipients: a single center experience.
    Rihani R; Hayajneh W; Sultan I; Ghatasheh L; Abdel-Rahman F; Hussein N; Hussein A; Al-Zaben A; Sarhan M; Saad M
    Bone Marrow Transplant; 2011 Nov; 46(11):1430-6. PubMed ID: 21243021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Iwakuni O; Egashira K; Yamaji K; Kashiwagi S
    J Infect Chemother; 2012 Apr; 18(2):180-6. PubMed ID: 22193710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and molecular epidemiology of the novel influenza A (H1N1) infection in children in Shanghai].
    Wang XS; Cai JH; Yao WL; Ge YL; Zhu QR; Zeng M
    Zhonghua Er Ke Za Zhi; 2013 May; 51(5):356-61. PubMed ID: 23941842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015.
    Tandel K; Sharma S; Dash PK; Parida M
    J Med Virol; 2018 May; 90(5):836-843. PubMed ID: 29288584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(32):893-6. PubMed ID: 19696719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
    Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
    N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria.
    Poeppl W; Hell M; Herkner H; Stoiser B; Fritsche G; Schurz-Bamieh N; Poeppl G; Gattringer R; Jones N; Maass M; Egle A; Burgmann H
    Infection; 2011 Aug; 39(4):341-52. PubMed ID: 21544585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.
    Storms AD; Gubareva LV; Su S; Wheeling JT; Okomo-Adhiambo M; Pan CY; Reisdorf E; St George K; Myers R; Wotton JT; Robinson S; Leader B; Thompson M; Shannon M; Klimov A; Fry AM;
    Emerg Infect Dis; 2012 Feb; 18(2):308-11. PubMed ID: 22305467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection.
    Viasus D; Paño-Pardo JR; Pachón J; Riera M; López-Medrano F; Payeras A; Fariñas MC; Moreno A; Rodríguez-Baño J; Oteo JA; Ortega L; Torre-Cisneros J; Segura F; Carratalà J;
    Chest; 2011 Oct; 140(4):1025-1032. PubMed ID: 21415133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
    Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
    J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.